Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,768,540
+$68,937 QoQ
Shares Held
18,776
-2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.91%
of 13F equity value
Holder Rank
#1,651
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHSTAR ASSET MANAGEMENT Co holds $10,204,107 across 8 Drug Manufacturers - General names. JNJ ranks #1 (46.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
18,776 | $4,768,540 | |
| 2 | NVS |
Novartis AG
|
13,875 | $2,174,490 | |
| 3 | NVO |
Novo Nordisk A S
|
18,853 | $903,812 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,130 | $787,705 | |
| 5 | LLY |
ELI LILLY & Co
|
617 | $740,048 | |
| 6 | ABBV |
AbbVie Inc.
|
2,065 | $519,636 | |
| 7 | PFE |
Pfizer Inc
|
11,074 | $266,661 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
750 | $43,215 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,768,540 | 18,776 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $4,699,603 | 19,226 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,063,670 | 19,636 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,741,033 | 20,176 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,112,434 | 20,376 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,486,951 | 21,026 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,091,397 | 21,376 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,488,503 | 21,526 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $3,237,590 | 22,151 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,622,076 | 22,897 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $3,682,919 | 23,497 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $5,402,967 | 34,690 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $5,750,164 | 34,740 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $5,376,950 | 34,690 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,243,693 | 35,345 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,778,042 | 35,370 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $6,256,339 | 35,245 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,294,677 | 35,517 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $6,178,534 | 36,117 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $5,829,019 | 36,093 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $5,941,841 | 36,068 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,279,484 | 38,208 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $6,179,368 | 39,264 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $5,751,829 | 38,634 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $5,349,423 | 38,039 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $4,971,662 | 37,914 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||